In keeping with these findings, TAM from HGSC patients show a high degree of phenotypic, ontogenetic and tumour‐promoting heterogeneity, reflected, for example, by the differential expression of CD163 and cytokines associated with tumour progression.17, 18. The gene discussed is CD163; the disease is neoplasm.